none film-coated tablet
iron (as ferrous sulfate heptahydrate) , folic acid - film-coated tablet - 60 mg (equivalent to to 300 mg ferrous sulfate heptahydrate)/ 250 mcg
appetason syrup (oral drops)
ad-drugstel pharmaceutical laboratories, inc - vitamin b complex , ferrous sulfate , l-lysine appetason - syrup (oral drops) - thiamine hcl (vitamin b1) 2.5 mg riboflavin (vitamin b2) 2.5 mg niacinamide (vitamin b3) 15 mg pyridoxine hcl (vitamin b6) 600 mg cyanocobalamin (vitamin b12) 1.5 mg l-lysine 75 mg ferrous sulfate heptahydrate 75 mg
ferrous sulfate (as heptahydrate) 75mg + 0.6ml (equivalent to 15mg elemental iron) syrup (oral drops)
medical center trading corporation - ferrous sulfate (as heptahydrate) - syrup (oral drops) - 75mg + 0.6ml (equivalent to 15mg elemental iron)
fero-gradumet 525 mg coat. tabl. vial
teofarma s.r.l. - ferrous sulfate heptahydrate 525 mg - eq. iron 105 mg - coated tablet - 525 mg - ferrous sulfate heptahydrate 525 mg - iron and multivitamins
ferograd 525 mg - 500 mg coat. tabl. vial
teofarma s.r.l. - ferrous sulfate heptahydrate 525 mg - eq. iron 105 mg; sodium ascorbate 500 mg - coated tablet - 525 mg - 500 mg - ferrous sulfate heptahydrate 525 mg; sodium ascorbate 500 mg - iron and multivitamins
ferro-liquid
aft pharmaceuticals ltd - ferrous sulfate heptahydrate 30 mg/ml; ferrous sulfate heptahydrate 30 mg/ml - oral solution - 30 mg/ml - active: ferrous sulfate heptahydrate 30 mg/ml excipient: citric acid ethyl hydroxybenzoate lime flavour fn-20202 nitrogen orange flavour fn-20212 propyl hydroxybenzoate purified water sodium bisulfite sodium citrate dihydrate sodium cyclamate sorbitol sucrose sunset yellow fcf active: ferrous sulfate heptahydrate 30 mg/ml excipient: citric acid nitrogen purified water sodium bisulfite sodium chloride sodium citrate dihydrate sorbitol strawberry flavour fn-20072 sucrose - iron deficiency and iron deficiency anaemias.
ferrograd f
abbott laboratories (nz) ltd - ferrous sulfate heptahydrate 325mg (in iron layer); folic acid 0.35mg (in folic acid layer) - modified release tablet - active: ferrous sulfate heptahydrate 325mg (in iron layer) folic acid 0.35mg (in folic acid layer) excipient: acacia acetone castor oil cellacefate colloidal silicon dioxide ethanol lactose monohydrate macrogol 8000 magnesium stearate as 6.15mg in iron layer and 3.05mg in folic acid layer maize starch methyl acrylate-methyl methacrylate copolymer ponceau 4r povidone as 8.55mg in iron layer and 1.5mg in folic acid layer propylene glycol purified water sorbitan oleate sucrose titanium dioxide
nat heme
mega lifesciences (australia) pty ltd - ferrous sulfate heptahydrate, quantity: 67.23 mg (equivalent: iron, qty 13.5 mg); haemoglobin, quantity: 500 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; magnesium stearate; iron oxide red; purified water; titanium dioxide; crospovidone; lactose monohydrate; pregelatinised maize starch; microcrystalline cellulose; calcium hydrogen phosphate dihydrate; polysorbate 80; purified talc; macrogol 4000; polyvinyl alcohol
hematogen- ferrous fumarate, ascorbic acid, intrinsic factor , cyanocobalamin capsule
nnodum pharmaceuticals - ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), intrinsic factor (unii: 70bt6oqt2q) (intrinsic factor - unii:70bt6oqt2q), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - ferrous cation 66 mg - for the treatment of all anemias responsive to oral iron therapy, such as hypochromic anemia associated with pregnancy, chronic or acute blood loss, dietary restriction, metabolic disease and post-surgical convalescence. hemochromatosis and hemosiderosis are contraindications to iron therapy.
ferrous sulfate- ferrous sulfate, dried tablet, film coated
spirit pharmaceuticals,llc - ferrous sulfate, dried (unii: rib00980vw) (iron - unii:e1uol152h7) - ferrous sulfate, dried 325 mg - iron supplement therapy ferrous sulphate is an iron supplement for iron deficiency and iron deficiency anemia when the need for such therapy has been determined by a physician.